Clinical trial
LAM Pilot Study With Imatinib Mesylate
NCT03131999 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- LAM Pilot Study With Imatinib Mesylate
- Lead sponsor
- Medical University of South Carolina
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- January 23, 2018
- Completion date
- March 7, 2019
- Enrollment
- 18 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.